Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Orlistat PD Endpoint Determination during BE study [Design Issues]

posted by Mei San – Malaysia, 2015-03-03 06:36 (4136 d 23:55 ago) – Posting: # 14534
Views: 8,311

Dear all,

May I know if anyone has experience on orlistat 120mg BE study before?

Many thanks.

Regards,
Mei San.

Complete thread:

Orlistat PD Endpoint Determination during BE studyMei San 2015-03-03 05:36
- Orlistat PD Endpoint Determination during BE study Dr_Dan 2015-03-04 09:50
  - Orlistat PD Endpoint Determination during BE study nobody 2015-03-04 10:39
    - Orlistat PD Endpoint Determination during BE study luvblooms 2015-03-09 06:44
      - Orlistat PD Endpoint Determination during BE study patilatu 2015-03-09 07:36

Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
318 visitors (0 registered, 318 guests [including 33 identified bots]).
Forum time: 07:32 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious. Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz